Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series

Pan Luo, Jian-ling Zheng, Yi Liu, Lin Qiu, Xiu-lan Liu, Hui-ying Xue, Dong Liu and Juan Li
Download PDF
DOI: https://doi.org/10.7861/clinmed.2020-0348
Clin Med January 2021
Pan Luo
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*joint first authors
Roles: responsible pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian-ling Zheng
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*joint first authors
Roles: responsible pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Liu
BTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: associate chief pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Qiu
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiu-lan Liu
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui-ying Xue
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong Liu
CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
†joint corresponding authors
Roles: chief pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Li
CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
†joint corresponding authors
Roles: chief pharmacist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lijuan@tjh.tjmu.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 21 no. 1 e80-e83
DOI: 
https://doi.org/10.7861/clinmed.2020-0348
PubMed: 
33355217
Published By: 
Royal College of Physicians
Print ISSN: 
1470-2118
Online ISSN: 
1473-4893
History: 
  • Published online January 21, 2021.

Article Versions

  • Latest version (December 18, 2020 - 04:52).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
© Royal College of Physicians 2021. All rights reserved.

Author Information

  1. Pan Luo, responsible pharmacistA,*,
  2. Jian-ling Zheng, responsible pharmacistA,*,
  3. Yi Liu, associate chief pharmacistB,
  4. Lin Qiu, responsible pharmacistA,
  5. Xiu-lan Liu, responsible pharmacistA,
  6. Hui-ying Xue, responsible pharmacistA,
  7. Dong Liu, chief pharmacistC,† and
  8. Juan Li, chief pharmacistC,†⇑
  1. ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  2. BTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  3. CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  4. *joint first authors
  5. †joint corresponding authors
  1. Address for correspondence: Prof Juan Li, Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. E-mail: lijuan{at}tjh.tjmu.edu.cn

Article usage

Article usage: December 2020 to July 2022

AbstractFullPdf
Dec 2020202074
Jan 20212077298
Feb 202129657
Mar 202105022
Apr 202104030
May 202114312
Jun 202112917
Jul 202103714
Aug 202104617
Sep 202105027
Oct 202127823
Nov 202103936
Dec 202109513
Jan 202203012
Feb 202203115
Mar 202207011
Apr 202235221
May 202215816
Jun 20222717
Jul 20220429

Cited By...

  • 3 Citations
  • Google Scholar
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series
Pan Luo, Jian-ling Zheng, Yi Liu, Lin Qiu, Xiu-lan Liu, Hui-ying Xue, Dong Liu, Juan Li
Clinical Medicine Jan 2021, 21 (1) e80-e83; DOI: 10.7861/clinmed.2020-0348

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series
Pan Luo, Jian-ling Zheng, Yi Liu, Lin Qiu, Xiu-lan Liu, Hui-ying Xue, Dong Liu, Juan Li
Clinical Medicine Jan 2021, 21 (1) e80-e83; DOI: 10.7861/clinmed.2020-0348
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Introduction
    • Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Real-world use of the Breathing Pattern Assessment Tool in assessment of breathlessness post-COVID-19
  • Understanding the diagnosis and management of multisystem inflammatory syndrome in adults (MIS-A) in the UK: results of a national Delphi process
  • The clinical course of pneumomediastinum in patients with SARS-CoV-2 before invasive mechanical ventilation
Show more COVID-19 rapid report

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians